Lobbying Relationship

Client

Noramco

More records

Lobbying firm

ALSTON & BIRD LLP

More records

  • House and Senate Agriculture-FDA FY 2020 Appropriations legislation; FDA and USDA regulation of Cannabidiol (CBD).

Duration: to

General Issues: Health Issues

Spending: about $150,000 (But it's complicated. Here's why.)

Agencies lobbied since 2019: U.S. Senate, House of Representatives, Food & Drug Administration (FDA)

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist Covered positions?
Marc Scheineson Legislative Counsel, Rep. Bill Gradison (R-OH); FDA Associate Commissioner for Legislative Affairs
Theodore B. Schroeder Chief Counsel, U.S. Senator Christopher A. Coons

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

Termination
Q2 Report
Q1 Report
Q4 Report
Registration

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page